Rare Disease Advisor/LinkedIn
Sep 5, 2025, 10:59
New Study Featured by Rare Disease Advisor Reveals Quality-of-Life Challenges in Hemophilia
Rare Disease Advisor posted on LinkedIn:
”Regardless of treatment regimen or disease severity, patients with Hemophilia often shoulder a significant treatment and disease burden that adversely impacts quality of life, according to a study published in Haemophilia (World Federation of Hemophilia / Fédération mondiale de l’hémophilie).”
Read more here.
Stay updated with Hemostasis Today.
-
Sep 19, 2026, 10:34Nawsherwan Mohammad: ASH 2026 Guidelines Redefine How We Detect Iron Deficiency
-
Sep 19, 2026, 10:21Upcoming Podcast on Thalassaemia with The Lancet Haematology
-
Sep 19, 2026, 10:20Steve Helm: Cardiology and Anticoagulation Pharmacist Role Opens Near NYC
-
Sep 19, 2026, 10:12Omid Seidizadeh: A Great Pleasure to Speak on vWD at the 59th NordCoag Congress
-
Sep 19, 2026, 10:08Carsten Hansen: What Happens During a Sickle Cell Crisis?
-
Sep 19, 2026, 10:05Alan Nurden: Thyroid Hormones as Regulators of Acute Platelet Release
-
Sep 19, 2026, 10:02Oliver Weingärtner: What Can Real-World Data Teach Us about Long-Term Treatment Persistence in CP?
-
Sep 19, 2026, 09:55Ammar Alsughayir: When Transfusion Safety Becomes a Lifelong Commitment
-
Sep 19, 2026, 09:53Dilini Christina Ranasinghe: Exploring Red Cell Exchange in Sickle Cell Disease